Tobramycin 0.3%, dexamethasone 0.05%; oph. susp; contains benzalkonium chloride. Evaluate IOP prior to the initial prescription and renewal of the medication order. Perform ophthalmic examination with ...
Tobramycin 0.3%, dexamethasone 0.05%; oph. susp; contains benzalkonium chloride. Dexamethasone is a potent corticoid. Corticoids suppress the inflammatory response to a variety of agents and they can ...
HUENENBERG, Switzerland — Alcon has launched TobraDex ST ophthalmic suspension in the United States, the company announced in a press release. TobraDex ST ...
BRIDGEWATER, N.J.--(BUSINESS WIRE)--Amneal Pharmaceuticals, Inc. (NYSE: AMRX) (“Amneal” or the “Company”) today announced that it has received Abbreviated New Drug Application (ANDA) approval from the ...
NASHVILLE, Tenn.--(BUSINESS WIRE)-- Harrow (Nasdaq: HROW), a leading U.S. eyecare pharmaceutical company, today announced the completion of the transfer to Harrow of the New Drug Applications (NDAs) ...
Overview: Tobramycin is an injectable antibiotic that is used to treat certain serious bacterial infections. Serious side effects may include hearing loss, nerve damage, kidney damage, skin reactions, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback